Earlier this week, the United States Food and Drug Administration (FDA) approved a human trial for a blueberry-sized brain ...

Why do mental health diagnoses so often overlap? New genetic research reveals shared roots and points toward more effective ...

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...

LifeStance Health reports that 73% of patients see significant improvement in depression and 79% in anxiety after treatment, ...

Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...

Blood tests measuring the aging of certain white blood cells can predict cognitive and mood-related symptoms of depression, ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

Many common mental health disorders, including depression and anxiety, are associated with a tendency to internalize problems ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...

Researchers analyzed 153 participants aged 18-62 years (mean age, 36 years) diagnosed with BED and enrolled in the US Binge Eating Treatment and Recovery program between 2020 and 2023. Participants ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

Scientific review highlights the prevalence of major depressive disorders during the period, identifying its most risky stage ...